Vivo Capital, LLC - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, Vivo Capital, LLC held in its portfolio 47 assets valued at $1,547,066,991 (i.e. $1.55B).
The most valuable assets in the portfolio included: Terns Pharmaceuticals Inc ($216.02M), Cidara Therapeutics, Inc. ($211.32M), and Praxis Precision Medicines ($96.94M).
The chart below shows the top 10 valuable assets, and the table below shows the top 47 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Vivo Capital, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| Terns Pharmaceuticals Inc | 5346928 | 216015891 | Common |
| Cidara Therapeutics, Inc. | 956670 | 211318836 | Common |
| Praxis Precision Medicines | 328895 | 96938512 | Common |
| Cogent Biosciences Inc | 2398993 | 85212231 | Common |
| Trevi Therapeutics Inc | 5094668 | 63785243 | Common |
| Avadel Pharmaceuticals PLC | 2684109 | 57842549 | ADR |
| Compass Therapeutics Inc | 9545466 | 51259152 | Common |
| Dyne Therapeutics Inc | 2614960 | 51148618 | Common |
| Abivax SA - ADR | 359305 | 48454076 | SPONSORED ADS |
| DBV Technologies SA | 2461626 | 47189370 | SPONSORED ADS |
| SAB Biotherapeutics Inc | 11420000 | 42710800 | Common |
| Soleno Therapeutics Inc | 894909 | 41434287 | Common |
| Bright Minds Biosciences Inc | 501617 | 39146191 | Common |
| Sinovac Biotech Ltd. | 5903000 | 38192410 | SHS |
| Geron Corp | 27225292 | 35937385 | Common |
| Erasca Inc | 9273428 | 34497152 | Common |
| Zenas Biopharma Inc | 853495 | 30990403 | Common |
| Viridian Therapeutics Inc | 982576 | 30577765 | Common |
| Aclaris Therapeutics, Inc. | 8888888 | 26755553 | Common |
| CAMP4 Therapeutics Inc | 4246568 | 26031462 | Common |
| Tango Therapeutics Inc | 2154780 | 19091351 | Common |
| Alto Neuroscience Inc | 1035551 | 18432808 | Common |
| LB Pharmaceuticals Inc | 800000 | 17808000 | Common |
| Minerva Neurosciences Inc | 4322747 | 17377443 | Common |
| Oric Pharmaceuticals Inc | 2118384 | 17328381 | Common |
| Corvus Pharmaceuticals Holdings | 2234566 | 17206158 | Common |
| Olema Pharmaceuticals Inc | 671843 | 16796075 | Common |
| Pepgen Inc | 2325000 | 15135750 | Common |
| Design Therapeutics Inc | 1612903 | 15129030 | Common |
| Dianthus Therapeutics Inc | 353998 | 14588258 | Common |
| Moonlake Immunotherapeutics | 1000000 | 13180000 | Common |
| Cytomx Therapeutics Inc | 2884615 | 12288460 | Common |
| Unicycive Therapeutics | 1789916 | 10327815 | Common |
| Eupraxia Pharmaceuticals Inc | 1350000 | 10192500 | Common |
| Abeona Therapeutics, Inc. | 1842751 | 9711298 | Common |
| Verastem Inc | 1106524 | 8542365 | Common |
| Silence Therapeutics PLC | 1105454 | 6721160 | ADS |
| Monopar Therapeutics Inc | 90500 | 5909650 | Common |
| Surrozen Inc | 260000 | 5876000 | Common |
| Palisade Bio Inc | 2293578 | 5389908 | Common |
| Sera Prognostics Inc | 1650440 | 4868798 | Common |
| Instil Bio Inc | 292743 | 3220173 | Common |
| Pasithea Therapeutics Corp | 2100000 | 2709000 | Common |
| Tenax Therapeutics Inc | 208333 | 2539579 | Common |
| EnGene Holdings Inc | 285046 | 843736 | Warrants |
| Bolt Therapeutics Inc | 72414 | 395960 | Common |
| Precision Biosciences Inc | 4675 | 19449 | Common |